News on research and diagnostic development for pathogenic diseases.
The company is also working in parallel on an at-home test that would be over the counter and return results within an hour.
Released by the Pandemic Response Accountability Committee, the report looks at data on test volume, turnaround, cost, and usage at six federal agencies.
The contract was awarded under DARPA's Detect It with Gene Editing Technologies program, which aims to create a device to detect at least 10 pathogens.
The test has been authorized for use with individual respiratory specimens, as well as with pooled specimens containing up to five samples.
The company continues to face regulatory challenges in the US, but received CE marking for its DPP SARS-CoV-2 Antigen and IgM/IgG test systems.
